Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study-Reference-Cited by-同舟云学术

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

Published:2017-03-15 Issue:4 Volume:34 Page:311-319
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Bertolotti Marco^ORCID, ,Franchi Carlotta,Rocchi Marco B. L.,Miceli Andrea,Libbra M. Vittoria,Nobili Alessandro,Lancellotti Giulia,Carulli Lucia,Mussi Chiara

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-017-0448-8.pdf

Reference47 articles.

1. Spinewine A. Adverse drug reactions in elderly people: the challenge of safer prescribing. BMJ. 2008;336:956–7.

2. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–46.

3. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:56–64.

4. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992;2:23–8.

5. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252–7.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in cholesterol homeostasis associated with aging and with age-related conditions: pathophysiological and clinical implications;Journal of Gerontology and Geriatrics;2023-09

2. Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study;European Journal of Clinical Pharmacology;2022-07-05

3. Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study;BMC Public Health;2022-02-04

4. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients;Clinical Interventions in Aging;2021-07

5. Management of high cholesterol levels in older people;Geriatrics & Gerontology International;2019-03-22